JAMA Netw Open 2024 Mar 4
Adrenal-Permissive Germline HSD3B1 Allele and Prostate Cancer Outcomes.
Related Questions
A patient with low-volume but high-risk prostate cancer (Gleason 8 disease) has completed a course of RT and remains on ADT with 3-month depot injecti...
New comment by Medical Oncologist at Rocky Mountain Cancer Centers-Boulder ( January 19, 2026)
I have a patient in his 80s whose testosterone was rising on Lupron, switched to degarelix, and still rising - it's real because his PSA is increasing as well, and he only rec...